Quantcast
Factors Affecting the First Stage (Sensitization) - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
b. Factors Affecting the First Stage (Sensitization). Red blood cell
sensitization with antibody obeys the law of mass action. Thus, the reaction between
antigen on the RBC surface and antibody is reversible and the quantity of
cell-bound antibody at equilibrium will vary depending on the reaction conditions and the
equilibrium constant of the antibody. The reaction conditions should be designed to
maximize the quantity of cell-bound antibody at equilibrium in order to facilitate
detection of either blood group antigen or antibody. Some of these reaction conditions
are described below:
(1)  Temperature. Most blood group antibodies show their greatest reactivity
over a restricted temperature range, some reacting optimally at 4C, others at 37C.
Antibodies reacting optimally at 37C have been described as "warm" antibodies, and
those reacting optimally at lower temperatures as "cold" antibodies. Agglutinins
(antibodies) having maximum reactivity at one temperature may have sufficient thermal
amplitude to be active at others. Antibody activity is usually tested at room temperature
and at 37C. Antibodies active at 37C are the most clinically significant, although "cold"
antibodies cannot be ignored if they have a wide thermal amplitude (for example, above
30C). Antibodies only reacting at lower temperatures may be of importance in patients
subjected to hypothermia.
(2)  pH. The pH optima for antibody reactivity in most blood-group systems
have not been investigated. For anti-RhO(D), the optimum pH lies between 6.5 and 7.
Antibodies of other blood-group specificities may have different pH optima (for example,
some examples of anti-M react best at pH 5.5).
(3)  Incubation time. Time is required for the antibody RBC reaction to reach
equilibrium. The amount of time required to reach this state will depend upon other
variables. The rate of antibody binding is greatest initially, so incubation times for
routine laboratory procedures may be relatively short (for example, 15 to 30 minutes).
Ionic strength.
(4)
(a) The ionic strength of the reaction medium is one of the
physiochemical conditions that play an important role in the binding of antibody to RBC
antigens. Ionic strength is a measure of intensity of the electrical field resulting from
ions in solution. Electro-static forces (interaction of positive and negative charges) play
an important role in antibody reaction involving RBCs. Red blood cells carry a large
electronegative charge, which serves to keep them from spontaneously aggregating.
This enables them to function efficiently in oxygen transport by maintaining a maximum
surface area available for gas diffusion. When RBCs are suspended in an electrolyte
solution (0.85 percent NaCl), the cations (positive) are attracted to the negatively
charged RBCs, and the RBC becomes surrounded by a diffuse double layer ("ionic
cloud"), that travels with the RBC as if it were part of it. The outer edge of this layer is
called the surface of shear or the
MD0846
1-13



Medical News
Impact of childhood bullying still evident after 40 years
The negative social, physical and mental health effects of childhood...
medicalxpress.com
Experts call for higher exam pass marks to close performance gap between international and UK medical graduates
The pass mark for a two-part test that international medical...
medicalxpress.com
Is UK shale gas extraction posing a risk to public health?
More needs to be done to investigate the risks to...
medicalxpress.com
Small Practices: Down but Not Out
(MedPage Today) -- It's becoming harder and harder for small...
medpagetoday.com
“Intelligent” liner may improve prosthetic limb fit and function
When I lived in the triathlete town of San Diego...
scopeblog.stanford.edu
Obama: 8 million signed up for health care
Eight million people have signed up for health care through...
medicalxpress.com
FDA OKs Merck tablet to reduce ragweed allergies
U.S. regulators have again approved a Merck & Co. tablet...
medicalxpress.com
Researchers discover target for treating dengue fever
Two recent papers by a University of Colorado School of...
medicalxpress.com
Multitarget TB drug could treat other diseases, evade resistance
A drug under clinical trials to treat tuberculosis could be...
medicalxpress.com
Novel marker discovered for stem cells derived from human umbilical cord blood
The development of stem cell therapies to cure a variety...
medicalxpress.com
Study recalculates costs of combination vaccines
One of the most popular vaccine brands for children may...
medicalxpress.com
Obama: Enrollment in ACA Plans Hits 8 Million
WASHINGTON (MedPage Today) -- Enrollment in private health plans sold...
medpagetoday.com
IV Ketamine Rapidly Effective in PTSD
(MedPage Today) -- Patients with moderate to severe post-traumatic stress...
medpagetoday.com
Tracking flu levels with Wikipedia
Can monitoring Wikipedia hits show how many people have the...
medicalxpress.com
Our brains are hardwired for language
A groundbreaking study published in PLOS ONE by Prof. Iris...
medicalxpress.com
How the immune system prevents repeated malaria fever episodes in highly exposed children
Children in Mali (and many other regions where malaria is...
medicalxpress.com
Proteomics discovers link between muscle damage and cerebral malaria
Malaria-related complications remain a major cause of death for children...
medicalxpress.com
First genetic link discovered to difficult-to-diagnose breast cancer sub-type
Scientists have identified the first genetic variant specifically associated with...
medicalxpress.com
New pain relief targets discovered
Scientists have identified new pain relief targets that could be...
medicalxpress.com
Gene variant raises risk for aortic tear and rupture
Researchers from Yale School of Medicine and Celera Diagnostics have...
medicalxpress.com
   


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +